| ATS ECG OMT |
Atherosclerotic Electrocardiogram Optimal Medical Therapy |
| BMI | Body Mass Index |
| NSTE-ACS Omega-3 PUFAs |
group of patients with Non-ST elevation acute coronary syndromes treated with Omega-3 fatty acids (Omacor®) in addition to OMT |
| NSTE-ACS | group of patients with Non-ST elevation acute coronary syndromes with OMT without Omega-3 fatty acids (Omacor®) |
| STE-ACS Omega-3 PUFAs |
group of patients with ST elevation acute coronary syndromes treated with Omega-3 fatty acids (Omacor®) in addition to OMT |
| STE-ACS | group of patients with n ST elevation acute coronary syndromes with OMT without Omega-3 fatty acids (Omacor®) |
| LDL Cholesterol | Low Density Lipoprotein Cholesterol |
| HDL Cholesterol | High Density Lipoprotein Cholesterol |
| CK-MB ACEI | Creatine Kinase isoenzymes MB Angiotensin Converting Enzymes Inhibitors |
| FMD vWf TAS |
Flow-Mediated Dilation von Willebrand factor Total Antioxidant Status |
| Ab anti Ox LDL cholesterol |
antibodies anti-Oxidated Low Density Lipoprotein Cholesterol |
| Ac anti MPO IgG |
Antibodies anti-Myeloperoxidase Immunoglobulin G type |